Atlas Trials

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

Clinical trial NCT03241303 · COMPLETED

Trial details

NCT number
NCT03241303
Sponsor
University Hospital, Gentofte, Copenhagen
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Glucose Metabolism Disorders
Start date
2017-08-01
Primary completion
2018-01-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.